In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...
Pairwise has licensed its Fulcrum® gene editing platform to the International Rice Research Institute (IRRI), a non-profit agricultural research organization. The agreement will enable IRRI to apply ...
A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using ...
CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully ...
Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, affecting over half a million people each year and causing about 300,000 ...
An infant with a rare metabolic disease became the world’s first patient to be treated with a personalized CRISPR gene-editing treatment in a landmark study between Penn Medicine and the Children’s ...
Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, ...
urning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is turned on, the production of proteins or other substances is promoted; when it's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback